Inventors with similar research interests:
Location History:
- Tübingen, DE (2012)
- Tubingen, DE (2011 - 2016)
- Muenchen Schwabin, DE (2019)
- Schwabing, DE (2019)
- München Scwabing, DE (2019)
- Muenchen Schwabing, DE (2019 - 2020)
- München, DE (2020)
- Houston, TX (US) (2018 - 2021)
- München Schwabing, DE (2018 - 2021)
- Munich Schwabing, DE (2019 - 2021)
- Tuebingen, DE (2014 - 2024)
- Munich, DE (2017 - 2024)
Company Filing History:
502 out of 725 
1 out of 832,718 Years Active: 2011-2025
Areas of Expertise:
Title: Harpreet Singh: Pioneering Innovator in Personalized Immunotherapy
Introduction:
Harpreet Singh, an esteemed inventor in the field of personalized immunotherapy, has made significant contributions to the advancement of cancer treatment. Hailing from Munich, Germany, Singh has an impressive track record with over 402 patents to his name. In this article, we delve into his latest patents, career highlights, and notable collaborations.
Latest Patents:
Singh's recent patents focus on personalized immunotherapy against several neuronal and brain tumors. His inventions revolve around peptides, nucleic acids, and cells used in immunotherapeutic methods. Specifically, his work aims to stimulate anti-tumor immune responses by incorporating tumor-associated cytotoxic T cell (CTL) peptide epitopes into vaccine compositions. These compositions, when administered, trigger the body's immune system to target and combat cancer cells.
Additionally, Singh's patents explore the utilization of peptides, proteins, nucleic acids, and cells for immunotherapeutic treatments in various cancers. He emphasizes the use of tumor-associated T-cell peptide epitopes, both alone and in combination with other tumor-associated peptides, as active pharmaceutical ingredients in vaccine compositions. Applying these innovative techniques, Singh's work demonstrates the potential for stimulating anti-tumor immune responses and enhancing personalized cancer treatment.
Career Highlights:
Throughout his illustrious career, Harpreet Singh has been associated with leading biotechnology companies. Notably, he has contributed significantly to the success of Immatics Biotechnologies GmbH, an influential player in the field of cancer immunotherapies. Singh's expertise and insights have empowered the company to make significant strides in the development of targeted cancer treatments.
Collaborations:
Singh has been privileged to work alongside revered colleagues, Toni Weinschenk and Jens Fritsche. Collaborations of this nature offer ample opportunity for knowledge sharing, fostering innovation, and synergistic advancements. Their combined expertise and dedication to improving personalized immunotherapy reinforce the importance of collaboration in driving ground-breaking inventions.
Conclusion:
Harpreet Singh's extensive patent portfolio and pioneering work in personalized immunotherapy are truly inspirational. His dedication to advancing cancer treatment through the development of innovative vaccine compositions serves as a monumental contribution to the medical field. As Singh continues to explore strategies in stimulating anti-tumor immune responses, we eagerly anticipate further breakthroughs that may revolutionize cancer therapies. With unwavering commitment, Singh's contributions to the field of personalized immunotherapy will continue to have a lasting impact on cancer patients worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.